Last reviewed · How we verify

NCT05524870

The Effect of Manual Therapy on Central Sensitization

Completed NA Last updated 18 November 2023
What this trial tests

NA trial testing Mobilization in Subacromial Pain Syndrome in 63 participants. Completed in 5 February 2023.

Timeline
15 February 2022
Primary endpoint
1 February 2023
5 February 2023

Quick facts

Lead sponsorCukurova University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment63
Start date15 February 2022
Primary completion1 February 2023
Estimated completion5 February 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Cukurova University

Who can join

Adults 18 to 65, any sex, with Subacromial Pain Syndrome or Central Sensitisation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Subacromial pain syndrome (SIS) is a common cause of shoulder pain, estimated to be the cause for up to half of incident cases. Typically, pain is generated with elevation of the arm above the head though it can occur with rest in patients with SIS.There is evidence of central sensitization in those who experience chronic shoulder pain from SIS. Central sensitization is an augmentation of the nociceptive pathways of the central nervous system that is characterized by local and generalized lowered pain thresholds and an exaggerated pain response to painful and non painful stimulation.Mobilization with movement (MWM) technic is a kind of manual therapy and it is often used by clinicians for the treatment of musculoskeletal diseases. Usually manual therapy is used for its peripheral effects, however it also produces central analgesic effects activating descending anti-nociceptive pathways for a short period of time (30 - 35 mins.). Some speculate that repeated sessions of manual therapy may result in a long term activation of descending anti-nociceptive pathways. However, there is no evidence of this mechanism available yet. Therefore, the aim of this study is to investigate the effect of MWM on central sensitization (primary aim) and shoulder functions (secondary aim) in patients with SIS.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Mobilization with movement plus exercise versus exercise alone for patients with central sensitization associated with chronic subacromial pain syndrome: a sham-controlled randomized clinical trial.
    Deniz V, Kelle B. · · 2025 · PMID 40722073 · DOI 10.1186/s12906-025-05028-0

Verify or expand the search:

Other trials of Mobilization

Trials testing the same drug.

Other recruiting trials for Subacromial Pain Syndrome

Currently open trials in the same condition.

Other Cukurova University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05524870.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing